Ende Zhao

Ende Zhao is a Medical Director at Alexion Pharmaceuticals, Inc. since October 2024. With a robust background in oncology and immunology, Ende has served as an Expert Reviewer for over 30 prestigious SCI scientific journals, demonstrating extensive expertise in the field. Previous roles include Associate Director/Medical Monitor at FibroGen, Inc., where Ende led clinical trials in oncology, and Research Manager at NYU Langone Health, overseeing interventional and observational clinical trials. Ende's academic achievements include a PhD in Oncology and postdoctoral training in Tumor Immunology from the University of Michigan, alongside significant contributions to research as a Principal Investigator at Huazhong University of Science and Technology. Ende's diverse skill set encompasses clinical trial planning, protocol design, and the development of biomarkers for targeted therapies.